NCIt definition : An orally available small molecule, mutant-selective inhibitor of epidermal growth
factor receptor (EGFR) with potential antineoplastic activity. Olmutinib binds to
and inhibits mutant forms of EGFR, thereby leading to cell death of EGFR-expressing
tumor cells. As this agent is selective towards mutant forms of EGFR, its toxicity
profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit
the EGFR wild type form.;
UNII : CHL9B67L95;
InChIKey : FDMQDKQUTRLUBU-UHFFFAOYSA-N;
CAS number : 1353550-13-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1353550-13-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;